Is maximum tolerated dose (MTD) chemotherapy scheduling optimal for glioblastoma multiforme?
From MaRDI portal
Publication:6604202
Recommendations
- Blasting neuroblastoma using optimal control of chemotherapy
- Optimal Chemotherapy for Brain Tumor Growth in a Reaction-Diffusion Model
- Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy
- scientific article; zbMATH DE number 7640641
- Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model
Cites work
- A review of optimal chemotherapy protocols: from MTD towards metronomic therapy
- scientific article; zbMATH DE number 5703572 (Why is no real title available?)
- Mathematical biology. Vol. 2: Spatial models and biomedical applications.
- Mathematical oncology: using mathematics to enable cancer discoveries
- Maximization of viability time in a mathematical model of cancer therapy
- Minimization of Region-Scalable Fitting Energy for Image Segmentation
- Nonlinear partial differential equations with applications
- On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
- Optimal Chemotherapy for Brain Tumor Growth in a Reaction-Diffusion Model
- Optimal control of advective direction in reaction-diffusion population models
- Ultimate dynamics and optimal control of a multi-compartment model of tumor resistance to chemotherapy
Cited in
(1)
This page was built for publication: Is maximum tolerated dose (MTD) chemotherapy scheduling optimal for glioblastoma multiforme?
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6604202)